Priveterra Acquisition Corp. Business Finance Contracts & Agreements
41 Contracts & Agreements
- Funding Agreements (3 contracts)
- Guaranty Agreements (1)
- Note Agreements (10)
- Purchase Agreements (6)
- Registration Rights Agreements (3)
- Security Agreements (1)
- Stock Agreements (5)
- Subscription Agreements (5)
- Underwriting Agreements (3)
- Warrant Agreements (4)
- Underwriting Agreement between the Company and Aegis Capital Corp., dated January 6, 2025 (Filed With SEC on January 7, 2025)
- Form of Series B Warrant (Filed With SEC on January 7, 2025)
- Form of Series A Warrant (Filed With SEC on January 7, 2025)
- Senior Secured Convertible Note, dated April 12, 2024, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on April 17, 2024)
- AEON Biopharma, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on April 2, 2024)
- Senior Secured Convertible Note, dated March 24, 2024, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 28, 2024)
- Guaranty, dated March 19, 2024, by and between Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)
- Security Agreement, dated March 19, 2024, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)
- Subscription Agreement, dated March 19, 2024, by and between AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)
- Form of Senior Secured Convertible Note, by and among AEON Biopharma, Inc., Daewoong Pharmaceutical Co., LTD. and AEON Biopharma Sub, Inc (Filed With SEC on March 19, 2024)
- Amendment No. 1 to Note Subscription Agreement, dated June 23, 2023, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc., and Alphaeon 1, LLC (Filed With SEC on July 27, 2023)
- Note Subscription Agreement, dated as of June 27, 2023, by and among Priveterra Acquisition Corp., AEON Biopharma, and Alphaeon 1, LLC (Filed With SEC on July 27, 2023)
- Note Subscription Agreement, dated as of June 27, 2023, by and among Priveterra Acquisition Corp., AEON Biopharma, and Daewoong Co., Ltd (Filed With SEC on July 27, 2023)
- New Money PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and Polar Multi-Strategy Master Fund (Filed With SEC on July 27, 2023)
- New Money PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and ACM ARRT J LLC (Filed With SEC on July 27, 2023)
- FPA Funding Amount PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and Polar Multi-Strategy Master Fund (Filed With SEC on July 27, 2023)
- FPA Funding Amount PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and ACM ARRT J LLC (Filed With SEC on July 27, 2023)
- Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc. and Polar Multi-Strategy Master Fund (Filed With SEC on July 27, 2023)
- Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc. and ACM ARRT J LLC (Filed With SEC on July 27, 2023)
- Amended and Restated Registration Rights Agreement, dated as of July 21, 2023, by and between AEON Biopharma, Inc. and the stockholders party thereto (Filed With SEC on July 27, 2023)
- Form of New Money PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and the investors signatory thereto (Filed With SEC on June 30, 2023)
- Form of FPA Funding Amount PIPE Subscription Agreement, by and among Priveterra Acquisition Corp. and the investors signatory thereto (Filed With SEC on June 30, 2023)
- Form of Note Subscription Agreement, by and among Priveterra Acquisition Corp. and the investors signatory thereto (Filed With SEC on June 30, 2023)
- Form of Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc., and Polar Multi-Strategy Master Fund (Filed With SEC on June 30, 2023)
- Form of Forward Purchase Agreement, by and among Priveterra Acquisition Corp., AEON Biopharma, Inc., and ACM ARRT J LLC (Filed With SEC on June 30, 2023)
- Promissory Note, dated as of April 28, 2023, by and among Privaterra Acquisition Corp. and Priveterra Sponsor, LLC (Filed With SEC on May 1, 2023)
- Convertible Promissory Note, dated as of February 15, 2021, issued to Priveterra Sponsor, LLC (Filed With SEC on February 18, 2021)
- Private Placement Warrants Purchase Agreement, dated February 8, 2021, by and among the Company and Priveterra Sponsor, LLC (Filed With SEC on February 12, 2021)
- Registration Rights Agreement, dated February 8, 2021, by and among the Company, Priveterra Sponsor, LLC and the other holders party thereto (Filed With SEC on February 12, 2021)
- Investment Management Trust Agreement, dated February 8, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on February 12, 2021)
- Warrant Agreement, dated February 8, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on February 12, 2021)
- Underwriting Agreement, dated February 8, 2021, by and among the Company and Wells Fargo Securities, LLC and Guggenheim Securities, LLC, as representatives of the several... (Filed With SEC on February 12, 2021)
- Form of Registration Rights Agreement between the Registrant and the Holders signatory thereto (Filed With SEC on January 29, 2021)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 29, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 29, 2021)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 29, 2021)
- Specimen Warrant Certificate (Filed With SEC on January 29, 2021)
- Specimen Class A Common Stock Certificate (Filed With SEC on January 29, 2021)
- Form of Underwriting Agreement (Filed With SEC on January 29, 2021)
- Securities Subscription Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 21, 2021)
